Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

'I'm waiting for that': Interest in the use of PrEP for safer conception in Botswana.

Gutin SA, Harper GW, Amico KR, Bitsang C, Moshashane N, Harries J, Ramogola-Masire D, Morroni C.

Glob Public Health. 2020 Mar 16:1-12. doi: 10.1080/17441692.2020.1741663. [Epub ahead of print]

PMID:
32175819
2.

Botswana's HIV response: Policies, context, and future directions.

Ramogola-Masire D, Poku O, Mazhani L, Ndwapi N, Misra S, Arscott-Mills T, Blank L, Ho-Foster A, Becker TD, Yang L.

J Community Psychol. 2020 Apr;48(3):1066-1070. doi: 10.1002/jcop.22316. Epub 2020 Jan 17.

PMID:
31951283
3.

Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana.

Grover S, Zetola N, Ramogola-Masire D, Bvochora-Nsingo M, Schnader AF, Mick R, Gabaitiri L, Matlhagela K, Shen H, Chiyapo S, Balang D, Phaladze N, Nkomazana O, Friedman H, Jemmott J, Chilisa B, Robertson ES.

BMJ Open. 2019 Dec 30;9(12):e031103. doi: 10.1136/bmjopen-2019-031103.

4.

Assessing Nurses' Adherence to the See-and-Treat Guidelines of Botswana's National Cervical Cancer Prevention Programme.

Johnson LG, Ramogola-Masire D, Teitelman AM, Jemmott JB, Buttenheim AM.

Cancer Prev Res (Phila). 2020 Mar;13(3):329-336. doi: 10.1158/1940-6207.CAPR-19-0348. Epub 2019 Dec 18.

PMID:
31852663
5.

Performance of vaginal self-sampling for human papillomavirus testing among women living with HIV in Botswana.

Elliott T, Kohler RE, Monare B, Moshashane N, Ramontshonyana K, Muthoga C, Wynn A, Howett R, Luckett R, Morroni C, Ramogola-Masire D.

Int J STD AIDS. 2019 Oct;30(12):1169-1176. doi: 10.1177/0956462419868618. Epub 2019 Sep 27. No abstract available.

PMID:
31558129
6.

Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.

Luckett R, Mogowa N, Li HJ, Erlinger A, Hacker MR, Esselen K, Feldman S, Shapiro R, Morroni C, Ramogola-Masire D.

Obstet Gynecol. 2019 Oct;134(4):840-849. doi: 10.1097/AOG.0000000000003496.

PMID:
31503167
7.

HPV self-sampling acceptability and preferences among women living with HIV in Botswana.

Kohler RE, Elliott T, Monare B, Moshashane N, Ramontshonyana K, Chatterjee P, Ramogola-Masire D, Morroni C.

Int J Gynaecol Obstet. 2019 Dec;147(3):332-338. doi: 10.1002/ijgo.12963. Epub 2019 Oct 2.

PMID:
31489627
8.

Perspectives about childbearing and pregnancy planning amongst people living with HIV in Gaborone, Botswana.

Gutin SA, Harper GW, Bitsang C, Moshashane N, Ramogola-Masire D, Harries J, Morroni C.

Cult Health Sex. 2019 Sep 3:1-17. doi: 10.1080/13691058.2019.1650202. [Epub ahead of print]

PMID:
31478784
9.

Scaling up diagnostic-driven management of sexually transmitted infections in pregnancy.

Wynn A, Moucheraud C, Morroni C, Ramogola-Masire D, Klausner JD, Leibowitz A.

Lancet Infect Dis. 2019 Aug;19(8):809-810. doi: 10.1016/S1473-3099(19)30351-2. No abstract available.

10.

Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study.

Iyer HS, Kohler RE, Ramogola-Masire D, Brown C, Molebatsi K, Grover S, Kablay I, Bvochora-Nsingo M, Efstathiou JA, Lockman S, Tapela N, Dryden-Peterson SL.

PLoS One. 2019 Jun 6;14(6):e0218094. doi: 10.1371/journal.pone.0218094. eCollection 2019.

11.

Using partner notification to address curable sexually transmitted infections in a high HIV prevalence context: a qualitative study about partner notification in Botswana.

Wynn A, Moucheraud C, Moshashane N, Offorjebe OA, Ramogola-Masire D, Klausner JD, Morroni C.

BMC Public Health. 2019 May 29;19(Suppl 1):606. doi: 10.1186/s12889-019-6813-2.

12.

Adherence to screening appointments in a cervical cancer clinic serving HIV-positive women in Botswana.

Barchi F, Winter SC, Ketshogile FM, Ramogola-Masire D.

BMC Public Health. 2019 Mar 18;19(1):318. doi: 10.1186/s12889-019-6638-z.

13.

HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.

Grover S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, Bhatia RK, Balang D, Chiyapo SP, Luckett R, Ramogola-Masire D, Dryden-Peterson SL, Lin LL, Shin SS, Zetola NM.

Cancer. 2019 May 15;125(10):1645-1653. doi: 10.1002/cncr.31972. Epub 2019 Feb 25.

PMID:
30801696
14.

Factors Related to Advanced Stage of Cancer Presentation in Botswana.

Anakwenze C, Bhatia R, Rate W, Bakwenabatsile L, Ngoni K, Rayne S, Dhillon P, Narasimhamurthy M, Ho-Foster A, Ramogola-Masire D, Grover S.

J Glob Oncol. 2018 Dec;4:1-9. doi: 10.1200/JGO.18.00129.

15.

Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.

Papasavvas E, Kossenkov AV, Azzoni L, Zetola NM, Mackiewicz A, Ross BN, Fair M, Vadrevu S, Ramogola-Masire D, Sanne I, Firnhaber C, Montaner LJ.

Carcinogenesis. 2019 Apr 29;40(2):225-233. doi: 10.1093/carcin/bgy149.

PMID:
30364933
16.

Availability of WHO Essential Medicines for Cancer Treatment in Botswana.

Martei YM, Chiyapo S, Grover S, Ramogola-Masire D, Dryden-Peterson S, Shulman LN, Tapela N.

J Glob Oncol. 2018 Sep;4:1-8. doi: 10.1200/JGO.17.00063.

17.

Breast Cancer Pathology Turnaround Time in Botswana.

Martei YM, Narasimhamurthy M, Prabhakar P, Hutson J, Setlhako DI, Chiyapo S, Ramogola-Masire D, Makozhombwe I, Feldman M, Kayembe MKA, Grover S.

J Glob Oncol. 2018 Sep;4:1-7. doi: 10.1200/JGO.17.00090. Epub 2017 Nov 9.

18.

Unintended Pregnancy in Gaborone, Botswana: A Cross-Sectional Study.

Doherty K, Arena K, Wynn A, Offorjebe OA, Moshashane N, Sickboy O, Ramogola-Masire D, Klausner JD, Morroni C.

Afr J Reprod Health. 2018 Jun;22(2):76-82. doi: 10.29063/ajrh2018/v22i2.8.

PMID:
30052336
19.

Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.

Grover S, Bvochora-Nsingo M, Yeager A, Chiyapo S, Bhatia R, MacDuffie E, Puri P, Balang D, Ratcliffe S, Narasimhamurthy M, Gwangwava E, Tsietso S, Kayembe MKA, Ramogola-Masire D, Dryden-Peterson S, Mahantshetty U, Viswanathan AN, Zetola NM, Lin LL.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):201-210. doi: 10.1016/j.ijrobp.2018.01.067. Epub 2018 Feb 1.

20.

Achieving public and global health competencies: A teaching case study of Botswana's cervical cancer screening program.

Okatch H, Sowicz TJ, Teng H, Ramogola-Masire D, Buttenheim AM.

Public Health Nurs. 2018 May;35(3):238-245. doi: 10.1111/phn.12389. Epub 2018 Feb 9.

PMID:
29424085
21.

Prevalence and treatment outcomes of routine Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing during antenatal care, Gaborone, Botswana.

Wynn A, Ramogola-Masire D, Gaolebale P, Moshashane N, Sickboy O, Duque S, Williams E, Doherty K, Klausner JD, Morroni C.

Sex Transm Infect. 2018 May;94(3):230-235. doi: 10.1136/sextrans-2017-053134. Epub 2017 Nov 2.

22.

Multidisciplinary Gynecologic Oncology Clinic in Botswana: A Model for Multidisciplinary Oncology Care in Low- and Middle-Income Settings.

Grover S, Chiyapo SP, Puri P, Narasimhamurthy M, Gaolebale BE, Tapela N, Ramogola-Masire D, Kayembe MKA, Moloi T, Gaolebale PA.

J Glob Oncol. 2017 Feb 8;3(5):666-670. doi: 10.1200/JGO.2016.006353. eCollection 2017 Oct.

23.

Partner notification and treatment for sexually transmitted infections among pregnant women in Gaborone, Botswana.

Offorjebe OA, Wynn A, Moshashane N, Joseph Davey D, Arena K, Ramogola-Masire D, Gaolebale P, Morroni C, Klausner JD.

Int J STD AIDS. 2017 Oct;28(12):1184-1189. doi: 10.1177/0956462417692455. Epub 2017 Feb 6.

24.

Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications.

Ermel A, Qadadri B, Tong Y, Orang'o O, Macharia B, Ramogola-Masire D, Zetola NM, Brown DR.

Infect Agent Cancer. 2016 Nov 11;11:56. eCollection 2016.

25.

HIV Infection and Survival Among Women With Cervical Cancer.

Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, Grover S, Chiyapo S, Ramogola-Masire D, Kebabonye-Pusoentsi M, Clayman R, Mapes AC, Tapela N, Asmelash A, Medhin H, Viswanathan AN, Russell AH, Lin LL, Kayembe MKA, Mmalane M, Randall TC, Chabner B, Lockman S.

J Clin Oncol. 2016 Nov 1;34(31):3749-3757. doi: 10.1200/JCO.2016.67.9613.

26.

Integrating Human Immunodeficiency Virus and Reproductive, Maternal and Child, and Tuberculosis Health Services Within National Health Systems.

Joseph Davey D, Myer L, Bukusi E, Ramogola-Masire D, Kilembe W, Klausner JD.

Curr HIV/AIDS Rep. 2016 Jun;13(3):170-6. doi: 10.1007/s11904-016-0316-x. Review.

27.

Acceptability and Feasibility of Sexually Transmitted Infection Testing and Treatment among Pregnant Women in Gaborone, Botswana, 2015.

Wynn A, Ramogola-Masire D, Gaolebale P, Moshashane N, Agatha Offorjebe O, Arena K, Klausner JD, Morroni C.

Biomed Res Int. 2016;2016:1251238. doi: 10.1155/2016/1251238. Epub 2016 Mar 28.

28.

Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic Setting.

Brown CA, Suneja G, Tapela N, Mapes A, Pusoentsi M, Mmalane M, Hodgeman R, Boyer M, Musimar Z, Ramogola-Masire D, Grover S, Nsingo-Bvochora M, Kayembe M, Efstathiou J, Lockman S, Dryden-Peterson S.

Oncologist. 2016 Jun;21(6):731-8. doi: 10.1634/theoncologist.2015-0387. Epub 2016 Apr 6.

29.

Pharmacogenetics of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in resource-limited settings: Influence on antiretroviral therapy response and concomitant anti-tubercular, antimalarial and contraceptive treatments.

Russo G, Paganotti GM, Soeria-Atmadja S, Haverkamp M, Ramogola-Masire D, Vullo V, Gustafsson LL.

Infect Genet Evol. 2016 Jan;37:192-207. doi: 10.1016/j.meegid.2015.11.014. Epub 2015 Nov 18. Review.

PMID:
26602158
30.

Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs.

Grover S, Raesima M, Bvochora-Nsingo M, Chiyapo SP, Balang D, Tapela N, Balogun O, Kayembe MK, Russell AH, Monare B, Tanyala S, Bhat J, Thipe K, Nchunga M, Mayisela S, Kizito B, Ho-Foster A, Gaolebale BE, Gaolebale PA, Efstathiou JA, Dryden-Peterson S, Zetola N, Hahn SM, Robertson ES, Lin LL, Morroni C, Ramogola-Masire D.

Front Oncol. 2015 Nov 3;5:239. doi: 10.3389/fonc.2015.00239. eCollection 2015. Review.

31.

Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013.

Raesima MM, Forhan SE, Voetsch AC, Hewitt S, Hariri S, Wang SA, Pelletier AR, Letebele M, Pheto T, Ramogola-Masire D, El-Halabi S.

MMWR Morb Mortal Wkly Rep. 2015 Oct 16;64(40):1147-9. doi: 10.15585/mmwr.mm6440a5.

32.

Leveraging HIV Programming to Enhance Access to Noncommunicable Disease Care in Southern Botswana.

Reid MJ, Haas MK, Sedigeng P, Ramogola-Masire D, Friedman HM, Ho-Foster A.

J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):7-10. doi: 10.1177/2325957415569310. Epub 2015 Feb 5.

PMID:
25656859
33.

Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer.

Sobota RS, Ramogola-Masire D, Williams SM, Zetola NM.

Infect Agent Cancer. 2014 Aug 12;9:26. doi: 10.1186/1750-9378-9-26. eCollection 2014.

34.

Invasive cervical cancers from women living in the United States or Botswana: differences in human papillomavirus type distribution.

Ermel A, Ramogola-Masire D, Zetola N, Tong Y, Qadadri B, Azar MM, Brown DR.

Infect Agent Cancer. 2014 Jul 8;9:22. doi: 10.1186/1750-9378-9-22. eCollection 2014.

35.

A root-cause analysis of maternal deaths in Botswana: towards developing a culture of patient safety and quality improvement.

Madzimbamuto FD, Ray SC, Mogobe KD, Ramogola-Masire D, Phillips R, Haverkamp M, Mokotedi M, Motana M.

BMC Pregnancy Childbirth. 2014 Jul 16;14:231. doi: 10.1186/1471-2393-14-231.

36.

Case records of the Massachusetts General Hospital. Case 16-2014. A 46-year-old woman in Botswana with postcoital bleeding.

Ramogola-Masire D, Russell AH, Dryden-Peterson S, Efstathiou JA, Kayembe MK, Wilbur DC.

N Engl J Med. 2014 May 22;370(21):2032-41. doi: 10.1056/NEJMcpc1400839. No abstract available.

PMID:
24849087
37.

Examining the relationship between alcohol use and high-risk sex practices in a population of women with high HIV incidence despite high levels of HIV-related knowledge.

Zetola NM, Modongo C, Olabiyi B, Ramogola-Masire D, Collman RG, Chao LW.

Sex Transm Infect. 2014 May;90(3):216-22. doi: 10.1136/sextrans-2013-051244. Epub 2014 Jan 15.

38.

Cancer in Botswana: resources and opportunities.

Suneja G, Ramogola-Masire D, Medhin HG, Dryden-Peterson S, Bekelman JE.

Lancet Oncol. 2013 Jul;14(8):e290-1. doi: 10.1016/S1470-2045(13)70283-3. No abstract available.

PMID:
23816293
39.

High-resolution microendoscopy for the detection of cervical neoplasia in low-resource settings.

Quinn MK, Bubi TC, Pierce MC, Kayembe MK, Ramogola-Masire D, Richards-Kortum R.

PLoS One. 2012;7(9):e44924. doi: 10.1371/journal.pone.0044924. Epub 2012 Sep 18.

40.

Measuring stigma: are we looking in the right places?

Zetola NM, Olabiyi B, Ramogola-Masire D, Modongo C.

Int J Tuberc Lung Dis. 2012 Aug;16(8):1130-1. doi: 10.5588/ijtld.11.0824. No abstract available.

41.

Cervical cancer awareness and screening in Botswana.

Mingo AM, Panozzo CA, DiAngi YT, Smith JS, Steenhoff AP, Ramogola-Masire D, Brewer NT.

Int J Gynecol Cancer. 2012 May;22(4):638-44. doi: 10.1097/IGC.0b013e318249470a.

42.

Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana.

Ramogola-Masire D, de Klerk R, Monare B, Ratshaa B, Friedman HM, Zetola NM.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):308-13. doi: 10.1097/QAI.0b013e3182426227.

43.

A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana.

DiAngi YT, Panozzo CA, Ramogola-Masire D, Steenhoff AP, Brewer NT.

PLoS One. 2011;6(10):e25481. doi: 10.1371/journal.pone.0025481. Epub 2011 Oct 25.

44.

Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.

Ramogola-Masire D, McGrath CM, Barnhart KT, Friedman HM, Zetola NM.

Int J Gynecol Pathol. 2011 Nov;30(6):591-6. doi: 10.1097/PGP.0b013e31821bf2a6.

45.

Use of mobile telemedicine for cervical cancer screening.

Quinley KE, Gormley RH, Ratcliffe SJ, Shih T, Szep Z, Steiner A, Ramogola-Masire D, Kovarik CL.

J Telemed Telecare. 2011;17(4):203-9. doi: 10.1258/jtt.2011.101008. Epub 2011 May 6.

Supplemental Content

Loading ...
Support Center